The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A Bisaga, SD Comer, AS Ward, P Popik, HD Kleber… - …, 2001 - Springer
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …
被引用次数：175 相关文章

[引用][C] The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A BISAGA, SD COMER, AS WARD… - …, 2001 - pascal-francis.inist.fr
The NMDA antagonist memantine attenuates the expression of opioid physical dependence
in humans CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - search.ebscohost.com
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …
[PDF] researchgate.net

[PDF][PDF] The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - researchgate.net
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A Bisaga, S Comer, A Ward, P Popik, H Kleber… - …, 2001 - infona.pl
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - psycnet.apa.org
Evaluated whether memantine, a non-competitive NMDA receptor antagonist, decreases
naloxone-precipitated withdrawal in morphine-dependent humans. Eight heroin-dependent …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - pubmed.ncbi.nlm.nih.gov
Rationale Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …
[PDF] academia.edu

[PDF][PDF] The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - academia.edu
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - europepmc.org
Objective The present study evaluated whether memantine, the clinically available non-
competitive NMDA receptor antagonist, decreases naloxone-precipitated withdrawal in …

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

A Bisaga, SD Comer, AS Ward, P Popik… - …, 2001 - search.ebscohost.com
Rationale: Preclinical observations suggest that NMDA receptor-mediated glutamatergic
neurotransmission is involved in the expression and maintenance of opioid dependence …